The CDC told public health officials to be ready for a vaccine in early November.
In particular, local health departments would need to be ready to get the vaccine to health care workers and people in some high-risk groups. The documents were sent out on the same day that President Trump said in his speech at the Republican National Convention that a vaccine could be available by the end of the year.
. And back in early August, the president said he was optimistic that a vaccine would be ready "right around" the time of the November 3 election,Now the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and Sanofi have signedstating that they would make the “safety and well-being of vaccinated individuals our top priority,” continue to adhere to scientific and ethical standards for testing and manufacturing a vaccine, and to keep up enough supply and variety of vaccines available. The pledge also states that these companies will not seek approval or an emergency use authorization from the Food and Drug Administration until the vaccine meets the safety and efficacy standards of a Phase 3 clinical trial designed to meet the necessary standards for approval. AstraZeneca and Moderna each have a vaccine that's already in the Phase 3 stage,
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
9 Drugmakers Sign Safety Pledge In Rush To Develop Coronavirus VaccineNine drug companies have pledged not to submit vaccine candidates for FDA review until their safety and efficacy is shown in large clinical trials. The move is meant to bolster public confidence amid the rush to make a COVID-19 vaccine widely available.
Read more »
Companies working on coronavirus vaccines pledge to put science above politicsTop executives of nine drugmakers likely to produce the first coronavirus vaccines signed a pledge to boost public confidence in approved vaccines.
Read more »
9 Companies Pledge Not To Submit Coronavirus Vaccine To FDA Until It's Proved SafeTo reassure the public, nine companies issued a joint statement Tuesday saying they won't seek government approval for their coronavirus vaccines until full safety and effectiveness data are in hand.
Read more »
Pause in AstraZeneca vaccine trial not necessarily a setback, says UK health ministerBritain's Health Secretary Matt Hancock said on Wednesday that AstraZeneca's decision to pause its coronavirus vaccine trials was a challenge but would not necessarily set back efforts to develop a vaccine.
Read more »
AstraZeneca Pauses COVID-19 Vaccine Trial Due To Volunteer's IllnessNPR's Noel King talks to Paul Offit of the Vaccine Education Center at Children's Hospital of Philadelphia, about the coronavirus vaccine trial developed by AstraZeneca and the University of Oxford.
Read more »
COVID-19 vaccine candidate from Oxford University and AstraZeneca on hold after 'unexplained illness'The interruption in testing the Oxford vaccine candidate is the first major hiccup in a remarkably smooth effort to develop a coronavirus vaccine.
Read more »